Results 131 to 140 of about 784,460 (315)

IN SILICO INVESTIGATION AND DOCKING STUDIES OF E2F3 TUMOR MARKER: DISCOVERY AND EVALUATION OF POTENTIAL INHIBITORS FOR PROSTATE AND BREAST CANCER

, 2010
Sinosh Skariyachan, Shruthi Krishnan Rao, Usha B. Biradar   +2 more
openalex   +2 more sources

Expression of cathepsin E in pancreas: A possible tumor marker for pancreas, a preliminary report [PDF]

, 1996
Takeshi Azuma, Masamichi Hirai, Shigeji Ito, Kenji Yamamoto, R.T. Taggart, Takao Matsuba, Kiyoshi Yasukawa, Kouji Uno, Takanobu Hayakumo, Masatsugu Nakajima   +9 more
openalex   +1 more source

Supplementary Table 4 from Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

, 2023
Dharanija Madhavan, Manuela Zucknick, Markus Wallwiener, Katarina Ćuk, Caroline Modugno, Martina Scharpff, Sarah Schott, Jörg Heil, Andrey Turchinovich, Rongxi Yang, Axel Benner, Sabine Riethdorf, Andreas Trumpp, Christof Sohn, Klaus Pantel, Andreas Schneeweiß, Barbara Burwinkel   +16 more
openalex   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Evaluation of tumor marker in oral cancer patients.

, 1988
Hideo Kurokawa, Minoru Kajiyama, Shoji Tsuru, Tadao Sugimoto, Takahiro Kodama, Kajin Rin, T. Yamano, Masatoyo Arimatsu, Eiji Harada, Terumasa Tanaka, Hirohumi ETO, Etsuro Iino   +11 more
openalex   +2 more sources

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Clinical Significance of Tumor Marker Measurement in the Followup after Curative Resection for Breast Cancer

, 1998
Makoto Kojima, Masatoshi Oya, Shuichi Akao, Hiroshi Ishikawa   +3 more
openalex   +2 more sources

Significance of Baseline and Changes of Tumor Markers and Neutrophil-to-Lymphocyte Ratio in Predicting Overall Survival for Patients with Advanced Pancreatic Adenocarcinoma: A Retrospective Analysis

, 2023
Makoto Kadokura, Keisuke Tanaka, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Nobuyuki Enomoto   +5 more
openalex   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Investigating monoclonal antibody against cytokeratin 19 tumor marker. [PDF]

BMC Immunol
Momeni-Moghaddam MA, Mohammadnejad J, Ghahremani H, Khaghani S, Moradi N, Daemi A, Özbolat G, Döğüş Y, Hosseini ST.   +8 more
europepmc   +1 more source